MPM
VRTX icon

MBB Public Markets’s Vertex Pharmaceuticals VRTX Stock Holding History

MBB Public Markets’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-510
Closed -$227K – 473
2025
Q2 		$227K Sell
510
-116
-19% -$53.5K 0.02% 459
2025
Q1 		$303K Buy
+626
New +$292K 0.03% 419
2024
Q4 		– Sell
-630
Closed -$293K – 533
2024
Q3 		$293K Sell
630
-17,484
-97% -$8.4M 0.02% 457
2024
Q2 		$8.49M Buy
18,114
+17,389
+2,398% +$7.55M 0.17% 107
2024
Q1 		$303K Buy
+725
New +$306K 0.02% 212
2022
Q1 		– Sell
-1,984
Closed -$436K – 455
2021
Q4 		$436K Buy
+1,984
New +$386K 0.01% 249

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MBB Public Markets's VRTX Position: Q3 2025 in Review

MBB Public Markets sold out of Vertex Pharmaceuticals (VRTX) in Q3 2025, closing a stake of 510 shares — an estimated $227K sold.

MBB Public Markets first reported a position in VRTX in Q4 2021 and held it in 6 quarters. The position peaked at $8.49M in Q2 2024. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • MBB Public Markets reported no remaining Vertex Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • MBB Public Markets sold 510 Vertex Pharmaceuticals shares in Q3 2025, an estimated $227K.
  • MBB Public Markets first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 6 quarters.
  • MBB Public Markets's Vertex Pharmaceuticals position peaked at $8.49M in Q2 2024.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on MBB Public Markets's 13F filing for Q3 2025, filed 14 Nov 2025.